SULLIVAN TABLES Flashcards Preview

MES > SULLIVAN TABLES > Flashcards

Flashcards in SULLIVAN TABLES Deck (227):
1

CHARACTERIZED BY DISCRETE ATTACKS OF NEUROLOGICAL DEFICITS WITH EITHER FULL OR PARTIAL RECOVERY IN SUBSEQUENT WEEKS TO MONTHS

RELAPSING REMITTING MS

2

% OF RELAPSING REMITTING MS

85%

3

CHARACTERIZED BY LACK OF DISEASE PROGRESSION

RELAPSING REMITTING MS

4

MAY BE THE RESULT OF PROGRESSIVE AXONAL LOSS RATHER THAN NEW LESIONS

SECONDARY PROGRESSIVE MS

5

CHARACTERIZED BY DISEASE PROGRESSION AND STEADY FUNCTIONAL DECLINE FROM ONSET, PT. MAY EXPERIENCE MODEST FLUCTUATIONS IN NEUROLOGICAL DISABILITY BUT DISCRETE ATTACK DO NOT OCCUR

PRIMARY PROGRESSIVE MS

6

PRIMARY PROGRESSIVE MS %

10%

7

CHARACTERIZED BY STEADY DETERIORATION IN DISEASE FROM ONSET BUT WITH OCCASIONAL ACUTE ATTACKS

PROGRESSIVE RELAPSING MS

8

% OF PROGRESSIVE RELAPSING MS

5%

9

STABLE PATIENT MAY HAVE LOCAL INFLAMMATORY ACTIVITY THAT IS CLINICALLY ABSENT

RELAPSING REMITTING

10

ASSOCIATED WITH LATER ONSET (MEAN 40Y/O) AND MORE EQUAL GENDER DISTRIBUTION

PRIMARY PROGRESSIVE MS

11

INTERVALS IN BETWEEN ATTACKS ARE CHARACTERIZED BY CONTINUING DISEASE PROGRESSION

PROGRESSIVE RELAPSING MS

12

DEGENERATION OF CORTICOSPINAL TRACTS, NEURONS IN THE MOTOR CORTEX AND BRAINSTEM AND ANTERIOR HORN CELLS IN THE SC

ALS

13

DEGENERATION OF UMN

PRIMARY LATERAL SCLEROSIS

14

DEGENERATION OF MOTOR NEURONS OF CN 9-12

PROGRESSIVE BULBAR PALSY

15

LOSS OR CHROMATOLYSIS OF MOTOR NEURONS OF THE SC AND BRAINSTEM

PROGRESSIVE MUSCULAR ATOPHY

16

STAGE 1 HOEHN YAHR

MINIMAL/ABSENT ; UNILAT

17

STAGE 2 HOEHN YAHR

MINIMAL/BILATERAL/MIDLINE INVOLVEMENT, BALANCE INTACT

18

STAGE 3 HOEHN YAHR

IMPAIRED RIGHTING REFLEXES

19

STAGE 4 HOEHN YAHR

ALL SX PRESENT AND SEVERE, STANDING AND WALKING ONLY POSSIBLE WITH ASSIST

20

STAGE 5 HOEHN YAHR

CONFINED TO BED/W/C

21

pt. reacts inconsistently and nonpurposefully to stimuli in a nonspecific manner

GENERALIZED RESPONSE RLA 2

22

PT. APPEARS TO BE IN A DEEP SLEEP AND IS COMPLETELY UNRESPONSIVE TO STIMULI

RLA 1 NO RESPONSE

23

PT. REACTS SPECIFICALLY BUT INCONSISTENTLY TO STIMULI, MAY FOLLOW SIMPLE COMMAND SUCH AS CLOSING EYES IN AN INCONSISTENT DELAYED MANNER

RLA 3 LOCALIZED RESPONSE

24

HEIGHTENED STATE OF ACTIVITY, BIZARRE AND NON-PURPOSEFUL BEHAVIOR

RLA 4 CONFUSED AGIT

25

CONFABULATION PRESENT, DOES NOT DISCRIMINATE BETWEEN OBJECTS AND PERSONS.

RLA 4 CONFUSED AGIT

26

ABLE TO RESPOND TO SIMPLE COMMANDS FAIRLY CONSISTENTLY BUT RESPONSES ARE NON PURPOSEFUL OR FRAGMENTED WITH INC COMPLEXITY

RLA 5 CONFUSED INAPPROPRIATE

27

GOAL DIRECTED BEHAVIOR BUT IS DEPENDENT ON EXTERNAL INPUT OR DIRECTION

RLA 6 CONFUSED APP

28

GROSS ATTENTION TO ENVIRONMENT BUT IS HIGHLY DISTRACTIBLE AND LACKS ABILITY TO FOCUS ATTENTION ON A SPECIFIC TASK

RLA V

29

FOLLOWS SIMPLE DIRECTIONS CONSISTENTLY AND SHOWS CARRYOVER FOR RELEARNED TASKS SUCH AS SELF CARE

RLA VI

30

PAST MEMORIES SHOW MORE DEPTH AND DETAIL THAN RECENT MEMORY

RLA VI

31

PT APPEARS APPROPRIATE AND ORIENTED WITHIN HOSPITAL/HOME; ROBOT LIKE

RLA VII

32

SHOWS CARRYOVER FOR NEW LEARNING BUT AT A DECREASED RATE, JUDGMENT REMAINS IMPAIRED

RLA VII

33

BLUISH GRAY DISCOLORATION OF THE SKIN AND MUCUS MEMBRANE

CYANOSIS

34

REDDENED AREA OF SKIN D/T INCREASED BLOOD FLOW

ERYTHEMA

35

DIFFUSED REDNESS OF FACE RELATED TO EMOTION, FEVER AND INC TEMPERATURE

FLUSHING

36

TINY RED OR PURPLE HEMORRHAGIC SPOTS D/T CAPILLARY BLEEDING

PETECHIAE

37

NO PERCEPTIBLE PULSE EVEN WITH MAX PRESSURE

ABSENT - 0

38

BARELY PERCEPTIBLE , EASILY OBLITERATED WITH SLIGHT PRESSURE, FADES IN AND OUT

THREADY - 1+

39

DIFFICULT TO PALPATE, OBLITERATED WITH SLIGHT PRESSURE

WEAK - 2+

40

EASY TO PALPATE, REQUIRES MOD PRESSURE TO OBLITERATE

NORMAL 3+

41

VERY STRONG HYPERACTIVE, IS NOT OBLITERATED WITH MOD PRESSURE

BOUNDING 4+

42

ALTERNATES B/W PERIOD OF FEVER AND PERIOD OF NORMAL TEMPERATURE

INTERMITTENT

43

FLUCTUATES MORE THAN 3.6 F OR 2 C within a 24 hr period but remains above normal

REMITTENT

44

PERIODS OF FEVER ARE INTERSPERSED WITH NORMAL TEMP, EACH LAST AT LEAST ONE DAY AKA RECURRENT FEVER

RELAPSING

45

BODY TEMP MAY FLUCTUATE SLIGHTLY BUT IS CONSTANTLY ABOVE NORMAL

CONSTANT

46

MAS 0

NO INCREASE IN MM TONE

47

MAS 1

SLIGHT INCREASE IN MM TONE , MANIFESTED BY A CATCH AND RELEASE OR BY MIN RESISTANCE AT THE END OF THE ROM

48

MAS 1+

SLIGHT INCREASE IN MM TONE, WITH A CATCH, FOLLOWED BY MINIMAL RESISTANCE THROUGHOUT REMAINDER (< HALF OF ROM)

49

MAS 2

MORE MARKED INCREASED IN MM TONE BUT AFFECTED PART STILL EASILY MOVED

50

MAS 3

MARKED INCREASE IN MM TONE , PASSIVE MVT IS DIFFICULT

51

MAS 4

AFFECTED PART RIGID IN FLEXION OR EXTENSION

52

RAPID UPSTROKE AND DOWNSTROKE AND A SHORTENED PEAK

CORRIGAN'S / WATER HAMMER PULSE

53

REGULAR PULSE RHYTHM WITH ALTERNATION OF WEAK AND STRONG BEATS

PULSUS ALTERNANS

54

IRREGULAR PULSE RHYTHM IN WHICH PREMATURE BEATS ALTERNATE WITH SINUS BEATS

PULSUS BIGEMINUS

55

A STRONG UPSTROKE, DOWNSTROKE AND A SECOND UPSTROKE DURING SYSTOLE

PULSUS BISFERIENS

56

PULSE WITH A MARKEDLY DECREASED AMPLITUDE DURING INSPIRATION

PULSUS PARADOXUS

57

PULSUS BISFERIENS INDICATES?

AORTIC INSUFFICIENCY, AORTIC REGURGITATION AND AORTIC STENOSIS

58

CORRIGAN'S PULSE / WATER HAMMER PULSE

PATENT DUCTUS ARTERIOSUS

59

PULSUS PARADOXUS MAY INDICATE?

PERICARDIAL TAMPONADE

60

NORMAL RESPIRATIONS WITH EQUAL RATE AND DEPTH 12-20 CPM

EUPNEA

61

REGULAR BUT ABNORMALLY DEEP AND INCREASE IN RATE

KUSSMAUL'S RESPIRATION

62

IRREGULAR SHALLOW ALTERNATING WITH PERIODS OF APNEA

BIOT'S

63

GRADUAL INCREASE IN DEPTH FOLLOWED BY GRADUAL DECREASE AND THEN A PERIOD OF APNEA

CHEYNE-STOKES BREATHING

64

APNEA

THE ABSENCE OF BREATHING

65

SENSATION EXPERIENCED AT A SITE REMOTE FROM POINT OF STIMULATION

ALLESTHESIA

66

PAINFUL BURNING SENSATION ALONG THE DISTRIBUTION OF NN

CAUSALGIA

67

PAIN PRODUCED BY A NON NOXIOUS STIMULUS

ALLODYNIA

68

LOSS OF LIGHT TOUCH SENSIBILITY

THIGMANESTHESIA

69

TOUCH SENSATION PERCEIVED AS PAIN

DYSESTHESIA

70

ACCESSORY JT MOTION: ANKYLOSED JT

GRADE 0

71

ACCESSORY JT MOTION: CONSIDERABLE HYPOMOBILITY

GRADE 1

72

ACCESSORY JT MOTION: SLIGHT HYPOMOBILITY

GRADE 2

73

WHAT ACC JT MOTION GRADE/S IS GRADE 1 AND 2 JT MOB INDICATED?

GRADE 1 AND 2

74

ACCESSORY JT MOTION: NORMAL

GRADE 3

75

ACCESSORY JT MOTION: SLIGHT HYPERMOBILITY

GRADE 4

76

ACCESSORY JT MOTION: CONSIDERABLE HYPERMOBILITY

GRADE 5

77

ACCESSORY JT MOTION: UNSTABLE

GRADE 6

78

ACCESSORY JT MOTION: JT MOB IS NOT INDICATED AND SURGERY SHOULD BE CONSIDERED?

GRADE 0 AND GRADE 6

79

ATLEAST 50% BUT NOT FULL ROM AGAINST GRAVITY

3 -

80

LIGAMENTOUS INSTABILITY: GRADE 1

0-5 mm

81

LIGAMENTOUS INSTABILITY: GRADE 2

6-10 mm

82

LIGAMENTOUS INSTABILITY: GRADE 3

11-15 mm

83

LIGAMENTOUS INSTABILITY: GRADE 4

> 15 mm

84

PNS/SNS: hypervigilance

SNS

85

PNS/SNS: PUPILS CONSTRICT

PNS

86

PNS/SNS: HR DECREASES

PNS

87

PNS/SNS: GLUCOSE PRODUCTION AND RELEASE INCREASES

SNS

88

PNS/SNS: DIGESTION SLOWS

SNS

89

PNS/SNS: DIGESTION RETURNS

PNS

90

PNS/SNS: SWEATING INCREASES

SNS

91

PNS/SNS: SWEATING CEASES

PNS

92

PNS/SNS: BF TO MM INC , BF TO SKIN AND VISCERA DEC

SNS

93

PNS/SNS: BF TO SKIN AND VISCERA INC

PNS

94

PNS/SNS: ACTIVATION OF MASS MM

SNS

95

PNS/SNS: RELAXATION OF MUSCLES

PNS

96

PNS/SNS: BP INC

SNS

97

PNS/SNS: BRONCHODILATION

SNS

98

(+)/(-) FEATURE OF UMN: PARESIS

-

99

(+)/(-) FEATURE OF UMN: CLONUS

+

100

(+)/(-) FEATURE OF UMN: ASSOCIATED RXN

+

101

(+)/(-) FEATURE OF UMN: FATIGUE

-

102

(+)/(-) FEATURE OF UMN: BABINSKI

+

103

(+)/(-) FEATURE OF UMN: EXAGGERATED DTRS

+

104

(+)/(-) FEATURE OF UMN: SYNERGIES

+

105

(+)/(-) FEATURE OF UMN: LOSS OF DEXTERITY

-

106

(+)/(-) FEATURE OF UMN: DISTURBANCE IN MVT

+

107

JAW REFLEX

CN V

108

BICEPS REFLEX

C5-C6

109

BRACHIORADS REFLEX

C5,C6

110

TRICEPS REFLEX

C6,C7

111

ACHILLES REFLEX

S1-S2

112

LATERAL HAMS REFLEX

S1-S2

113

MEDIAL HAMS REFLEX

L4-L5

114

KNEE JERK

L2,L3,L4

115

UPPER ABDOMINAL REFLEX

T8-T10

116

LOWER ABDOMINAL REFLEX

T10-T12

117

GENERALIZED MUSCLE WEAKNESS

ASTHENIA

118

FLEXOR WITHDRAWAL ONSET AND INTEGRATION

28 WKS OF GESTATION; 1-2 MOS

119

CROSSED EXTENSION ONSET AND INTEGRATION

28 WKS OF GESTATION; 1-2 MOS

120

TRACTION ONSET AND INTEGRATION

28 WKS OF GESTATION; 2-5 MOS

121

MORO ONSET AND INTEGRATION

28 WKS OF GESTATION; 5-6 MOS

122

STARTLE ONSET AND INTEGRATION

AT BIRTH; PERSISTAS

123

GRASP ONSET AND INTEGRATION

PALMAR: BIRTH/PLANTAR: 28 WKS OF GESTATION
PALMAR: 4-6 MOS/PLANTAR: 9 MOS.

124

ATNR ONSET AND INTEGRATION

BIRTH ; 4-6 MOS

125

STNR ONSET AND INTEGRATION

4-6 MOS ; 8- 12 MOS

126

STLR ONSET AND INTEGRATION

BIRTH; 6 MOS

127

ASSOCIATED REACTION ONSET AND INTEGRATION

BIRTH - 3 MOS
8-9 YRS

128

POSSITIVE SUPPORTING ONSET AND INTEGRATION

BIRTH; 6 MOS

129

SPINAL/PRIMITIVE REFLEXES

MORO, STARTLE, GRASP, TRACTION, FLEXOR WITHDRAWAL, CROSSED EXTENSION

130

TONIC/BRAINSTEM REFLEXES

ATNR, STNR, STLR, ASSOCIATED RXNS AND POSITIVE SUPPORTING

131

INTRINSIC PATHOLOGY OR D/O

DISEASE

132

ANY LOSS OR ABNORMALITY OF PSYCHOLOGICAL, PHYSIOLOGICAL OR ANATOMICAL STRUCTURE OR FUNCTION

IMPAIRMENT

133

ANY RESTRICTION OR LACK OF ABILITY TO PERFORM AN ACTIVITY IN THE RANGE OF A NORMAL HUMAN

DISABILITY

134

DISADVANTAGE FOR A GIVEN INDIVIDUAL RESULTING FROM AN IMPAIRMENT OR DISABILITY THAT HINDERS THEM TO FULFILL A ROLE THAT IS NORMAL

HANDICAP

135

INTERRUPTION OR INTERFERENCE WITH NORMAL PROCESSES AND EFFORTS OF THE ORGANISM TO REGAIN NORMAL STATE

ACTIVE PATHOLOGY

136

LIMITATION IN PERFORMANCE AT THE LEVEL OF THE WHOLE ORGANISM/PERSON

FUNCTIONAL IMPAIRMENT

137

FEV1 IN MILD COPD

> 80 %

138

FEV1 MODERATE COPD

50-80%

139

FEV1 SEVERE COPD

30-50%

140

FEV1 VERY SEVERE COPD

< 30%

141

TRADENAME AND ACTION: ANTICHOLINERGIC

ATROVENT - BRONCHODILATION

142

TRADENAME AND ACTION: LONG ACTING BETA 2 AGONIST

SEREVENT - BRONCHODILATION

143

SIDE EFFECTS OF ANTICHOLINERGICS

THROAT IRRITATION,
DRYING OF TRACHEAL SECRETIONS
TACHYCARDIA
PALPITATIONS

144

SIDE EFFECTS OF SEREVENT

TACHYCARDIA
PALPITATIONS
GI DISTRESS
NERVOUSNESS
TREMOR
H/A
DIZZINESS

145

CROMOLYN SODIUM/INTAL: ACTION AND SIDE EFFECT

A: PREVENTS INFLAMMATION
S/E: BRONCHOSPASM
THROAT IRRITATION
COUGH

146

STEROIDS/FLOVENT/PREDNISONE: ACTION AND SIDE EFFECT

A: ANTI-INFLAMMATORY
S/E: INC BP
SODIUM RETENTION
MUSCLE WASTING
OSTEOPOROSIS
GI IRRITATION
ATHEROSCLEROSIS
HYPERCHOLESTEROLEMIA
INC SUSCEPTIBILITY TO INFECTION

147

LEUKOTRIENE RECEPTOR ANTAGONIST/SINGULAIR: ACTION AND SIDE EFFECT

A: BLOCKS ALLERGIC REACTION
S/E: GI DISTRESS
SORE THROAT
URTI
DIZZINESS
H/A AND NASAL CONESTION

148

METHYLXANTHINE

AMINOPHYLLINE
THEOPHYLLINE

149

METHYLXANTHINE: ACTION AND SIDE EFFECT

A: BRONCHODILATION
S/E: SEIZURE
CARDIAC ARRHYTHMIAS
GI DISTRESS
TREMOR AND H/A

150

NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:
CK MB

0-3% / 5% / 10% / 14-36 hrs

151

NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:
LDH

127 IU or 100-225 mU/mL / 300-750 mU/ml / >1000 mu/mL

152

NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:
TROPONIN

0-0.2 microgram/ml / 5 / 10 / 24-36 hrs

153

NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:
MYOGLOBIN

<100 ng/ml / 200ng/ml / > 500 ng/ml

154

HR/BP: BETA BLOCKERS

DEC/DEC

155

HR/BP: NITRATES

INC/DEC

156

HR/BP: CALCIUM CHANNEL BLOCKERS

DEC/DEC

157

HR/BP: DIGITALIS

DEC/NE

158

HR/BP: DIURETICS

NE/NE or dec

159

HR/BP: VASODILATORS

INC/DEC

160

HR/BP: ANTIADRENERGIC AGENTS s selective blockade

DEC/DEC

161

HR/BP: NICOTINE

INC/INC

162

FXNAL CLASS OF pt.s c HEART DSE: CLASS 1

4 - 6 cal/min ; 6.5 METS
without limitation in physical activity
ordinary activity - no sx

163

FXNAL CLASS OF pt.s c HEART DSE: CLASS 2

3-4 cal/min ; 4.5 METS
slight limitation in physical activity
ordinary act - (+) sx
no sx at rest

164

FXNAL CLASS OF pt.s c HEART DSE: CLASS 3

2-3 cal/min; 3 METS
marked limitation in physical activity
less than normal activity - (+) sx
no sx at rest

165

FXNAL CLASS OF pt.s c HEART DSE: CLASS 4

1-2 cal/min ; 1.5 MET
(+) sx with any activity and even at rest
inability to carryout any act without discomfort

166

NORMAL/LV/RV/BV: CVP

0-8 mmHg / 6 mmHg / 12 mmHg / 12 mmHg

167

NORMAL/LV/RV/BV: PAP

9-19 mmHg / 22 mmHg / 16 mmHg / 22 mmHg

168

NORMAL/LV/RV/BV: PCWP

6-12 mmHg / 18 mmHg / 10 mmHg / 18 mmHg

169

ASSOCIATED WITH RV FAILURE

INCREASED CVP

170

ASSOCIATED WITH LV FAILURE

INCREASE PAP AND PCWP

171

INPATIENT CARDIAC REHAB: LEVEL 1

1-1.5 METs - ESSENTIALLY BED REST
ARMS SUPPORTED
BED EXERCISES/SITTING DANGLED WITH FEET SUPPORTED
INTRODUCE TO CARDIAC REHAB

172

INPATIENT CARDIAC REHAB: LEVEL 2

1.5-2 METS - LIMITED ROOM AMBULATION
15-30 mins sitting - 3-4x/day
LEG EXERCISES
ELECTRIC RAZOR
COMMODE PRIVILEDGE
HEALING INTERVAL
EDUCATE ON RISK FACTORS

173

INPATIENT CARDIAC REHAB: LEVEL 3

2-2.5 METS - LIMITED HALL AMBULATION
ROOM OR HALL AMBULATION ~ 5' - 3-4x/day
OPTIONAL STANDING LEG EXERCISES
MANUAL SHAVE
BATHROOM PRIVILEDGE
EDUCATE ON SIZE OF INFARCT AND THE IMPACT OF EXERCISE AND BORG'S RPE

174

INPATIENT CARDIAC REHAB: LEVEL 4

2.5-3 METs - PROGRESSIVE HALL AMBULATION
HALL AMBULATION 5-7' - 3-4x/day
STANDING TRUNK EXERCISES
EDUCATE ON PULSE TAKING AND OUTPATIENT CARDIAC REHAB

175

INPATIENT CARDIAC REHAB: LEVEL 5

3-4 METS - PROGRESSIVE HALL AMBULATION
HALL AMBULATION ~ 8-10'
ARM EXERCISES OPTIONAL
STANDING SHOWER
WRITTEN HEP

176

INPATIENT CARDIAC REHAB: LEVEL 6

4-5 MET - STAIR CLIMBING
FULL FLIGHT OF STAIRS UP AND DOWN ONE STEP AT A TIME

177

NO EVIDENCE OF HEMODYNAMIC COMPROMISE:
in the HR of beta blocked and non beta blocked pts.

beta blocked: not >12 bpm
non: not >20 bpm

178

NO EVIDENCE OF HEMODYNAMIC COMPROMISE: SBP

no drop: >10 mmHg
no rise: >30 mmHg

179

NO EVIDENCE OF HEMODYNAMIC COMPROMISE: RPE

<13/20

180

NON INVASIVE TEST TO EXAME LE FOR ISCHEMIA, FOLLOWING ELEVATION, LOWERING OF THE LIMB SHOULD RETURN THE SKIN OF THE LIMB TO A PINK COLOR, IF DARK RED AND TAKES >30s = (+) arterial insufficiency

RUBOR TEST FOR DEPENDENCY

181

FOR BOTH ARTERIAL AND VENOUS CIRCULATION, CHANGES IN LE VOLUME TESTED DURING REST, STANDING AND LIGHT WALKING; DETECTS VENOUS OBSTRUCTION AND ARTERIAL INFLOW

AIR PLETHYSMOGRAPHY (APG)

182

FOR ARTERIAL CIRCULATION, SPECIAL PROVE AND A HEATING ELEMENT MEASURE PROFUSION, MEASUREMENT OF OXYGEN AT SKIN LEVEL = what's happening at cellular level

PREDICTIVE FOR HEALING OF ULCERS AND AMPUTATION WOUNDS

TRANSCUTANEOUS OXYGEN (TcPO2)

183

MEASURES BLOOD FLOW IN SKIN using a modified laser doppler probe

PREDICTIVE FOR HEALING OF ULCERS AND AMPUTATION WOUNDS

SKIN PERFUSION PRESSURE (SPP) measurement

184

TIME IT TAKES FOR THE VEINS ON TOP OF FOOT TO REFILL IS RECORDED

VENOUS FILLING TIME

185

VENOUS FILLING TIME:
(N) VALUE
ARTERIAL INSUFFICIENCY
VENOUS INSUFFICIENCY

15s
>15s
<15s

186

LE IN DEPENDENT POSITION, PALPATE GREAT SAPHENOUS VEIN DISTAL TO KNEE with ONE HAND, other hand proximal to knee 6"(15.2cm), percuss,

positive if wave of fluid is felt at distal site = poss VALVULAR INCOMPETENCY

PERCUSSION TEST

187

MEASURES TIME REQUIRED TO REFILL THE VEINS IN THE DORSUM OF THE FOOT; elevate foot, place tourniquet at thigh to prevent backflow

trendelenburg test

188

TRENDELENBURG TEST: if within 5s veins distend before tourniquet is released?

VALVULAR INCOMPETENCE OF DEEP VEINS

189

TRENDELENBURG TEST: if within 5s veins distend after tourniquet is released?

VALVULAR INCOMPETENCE OF SUPERFICIAL VEINS

190

PURPLE OR MAROON LOCALIZED AREA OF DISCOLORED INTACT SKIN OR BLOOD FILLED BLISTER

SUSPECTED DEEP TISSUE INJURY

191

TISSUE IS PAINFUL , FIRM, MUSHY , BOGGY, WARMER OR COOLER COMPARED TO ADJACENT TISSUE

SUSPECTED DEEP TISSUE INJURY

192

INTACT SKIN WITH NONBLANCHABLE REDNESS

STAGE 1

193

AREA MAY BE PAINFUL, FIRM, SOFTER, WARMER, OR COOLER COMPARED TO ADJACENT TISSUE

STAGE 1

194

PARTIAL THICKNESS SKIN LOSS OF DERMIS

STAGE 2

195

SHALLOW OPEN ULCER WITH A RED PINK WOUND BED

STAGE 2

196

FULL THICKNESS TISSUE LOSS , SUB Q VISIBLE

STAGE 3

197

UNDERMINING / TUNNELING

STAGE 4

198

FULL THICKNESS WITH EXPOSED BONE , TENDON, MUSCLE

STAGE 4

199

FULL THICKNESS LOSS, BASE FILLED WITH SLOUGH(YELLOW, TAN, GRAY, GREEN/BROWN) AND ESCHAR

UNSTAGEABLE

200

DRAINAGE: CLEAR

TRANSUDATED

201

DRAINAGE: CLEAR OR TINGE OF RED/BROWN

SEROSANGUINEOUS

202

DRAINAGE: CREAMY, YELLOWISH

EXUDATE

203

DRAINAGE: YELLOW, BROWN

PUS

204

DRAINAGE: HUES OF YELLOW, BLUE, GREEN

INFECTED PUS

205

AFFECTED PRIMARY MOTOR AREA AND MEDIAL ASPECT OF CORTEX AND INTERNAL CAPSULE

C/L HEMIPARESIS LE>UE - ACA

206

AFFECTED PRIMARY SENSORY AREA AND MEDIAL ASPECT OF CORTEX

C/L HEMISENSORY LOSS LE>UE - ACA

207

AFFECTED CORPUS CALLOSUM

PROBLEMS WITH IMITATION AND BIMANUAL TASKS, APRAXIA

208

AFFECTED PM ASPECT OF SUPERIOR FRONTAL GYRUS

URINARY INCONTINENCE

209

VBA OCCLUSION: I/L PARALYSIS WITH ATROPHY OF HALF THE TONGUE WITH DEVIATION TO PARALYZED SIDE WHEN TONGUE IS PROTRUDED

MEDIAL MEDULLARY SYNDROME

210

VBA OCCLUSION: TETRAPLEGIA

COMPLETE BASILARY ARTERY OR LOCKED IN

211

VBA OCCLUSION: DYSPHAGIA AND DYSPHONIA

HORNER'S SYNDROME

212

VBA OCCLUSION: I/L PARALYSIS OF CONJUGATE GAZE TO SIDE OF LESION

MEDIAL AND LATERAL INFERIOR PONTINE SYNDROME

213

VBA OCCLUSION: I/L NYSTAGMUS

WALLENBURG AND MEDIAL INFERIOR PONTINE SYNDROME

214

VBA OCCLUSION: DEAFNESS AND TINNITUS

LATERAL INFERIOR PONTINE SYNDROME

215

VBA OCCLUSION: I/L DIPLOPIA AT LATERAL GAZE

MEDIAL INFERIOR PONTINE

216

VBA OCCLUSION: (B) CRANIAL NN PALSY

COMPLETE BASILAR ARTERY

217

VBA OCCLUSION: COMA

COMPLETE BASILAR ARTERY

218

VBA OCCLUSION: HORIZONTAL AND VERTICAL NYSTAGMUS, NAUSEA, VOMITING AND VERTIGO

LATERAL INFERIOR PONTINE

219

VBA OCCLUSION: IMPAIRED TACTILE AND PROPRIOCEPTIVE SENSE

MEDIAL MEDULLARY AND MEDIAL INFERIOR PONTINE

220

VBA OCCLUSION: LIMB AND GAIT ATAXIA

LATERAL MEDULLARY AND MEDIAL INFERIOR PONTINE

221

VBA OCCLUSION: C/L IMPAIRED PAIN AND THERMAL SENSE OVER 50% OF BODY

HORNERS AND LATERAL INFERIOR PONTINE SYNDROME

222

VBA OCCLUSION: DEVIATION OF EYES

MEDIAL MIDPONTINE SYNDROME

223

VBA OCCLUSION: ATAXIA OF LIMBS

MEDIAL AND LATERAL MIDPONTINE SYNDROME

224

VBA OCCLUSION: PARALYSIS OF MM OF MASTICATION

LATERAL MIDPONTINE SYNDROME

225

VBA OCCLUSION: INTERNUCLEAR OPTHALMOPLEGIA

MEDIAL SUPERIOR PONTINE SYNDROME

226

VBA OCCLUSION: LOSS OF OPTOKINETIC NYSTAGMUS

LATERAL SUPERIOR PONTINE SYNDROME

227

VBA OCCLUSION: LOSS OF TOUCH VIBRATION AND POSITION SENSE MORE IN LE THAN UE

LATERAL SUPERIOR PONTINE SYNDROME